-
Fund Dashboard
- Holdings
Janus Henderson Global Life Sciences Fund
Fund Profile
Security | $Holding | Balance | % of Fund | Category | Position | Country |
---|---|---|---|---|---|---|
LLY Eli Lilly and Company | 483.98 mm | 546.29 k shares | 8.45 | Common equity | Long | USA |
UNH UnitedHealth Group Incorporated | 392.60 mm | 671.48 k shares | 6.85 | Common equity | Long | USA |
Novo Nordisk A/S SER'B'DKK0.1
|
265.19 mm | 2.26 mm shares | 4.63 | Common equity | Long | Denmark |
AZN AstraZeneca PLC | 208.97 mm | 1.35 mm shares | 3.65 | Common equity | Long | UK |
ABBV AbbVie Inc. | 206.47 mm | 1.05 mm shares | 3.60 | Common equity | Long | USA |
AMGN Amgen Inc. | 185.50 mm | 575.72 k shares | 3.24 | Common equity | Long | USA |
Sanofi EUR2
|
158.92 mm | 1.39 mm shares | 2.77 | Common equity | Long | France |
MRK Merck & Co., Inc. | 146.86 mm | 1.29 mm shares | 2.56 | Common equity | Long | USA |
BSX Boston Scientific Corporation | 144.11 mm | 1.72 mm shares | 2.52 | Common equity | Long | USA |
JNJ Johnson & Johnson | 142.12 mm | 876.96 k shares | 2.48 | Common equity | Long | USA |
ABT Abbott Laboratories | 136.40 mm | 1.20 mm shares | 2.38 | Common equity | Long | USA |
NVS Novartis AG | 129.85 mm | 1.13 mm shares | 2.27 | Long | USA | |
VRTX Vertex Pharmaceuticals Incorporated | 128.47 mm | 276.23 k shares | 2.24 | Common equity | Long | USA |
TMO Thermo Fisher Scientific Inc. | 113.32 mm | 183.20 k shares | 1.98 | Common equity | Long | USA |
ARGX argenx SE | 111.79 mm | 206.22 k shares | 1.95 | Long | USA | |
PCVX Vaxcyte, Inc. | 108.42 mm | 948.85 k shares | 1.89 | Common equity | Long | USA |
DHR Danaher Corporation | 106.67 mm | 383.69 k shares | 1.86 | Common equity | Long | USA |
SYK Stryker Corporation | 106.11 mm | 293.74 k shares | 1.85 | Common equity | Long | USA |
ISRG Intuitive Surgical, Inc. | 96.10 mm | 195.62 k shares | 1.68 | Common equity | Long | USA |
SRPT Sarepta Therapeutics, Inc. | 85.93 mm | 688.06 k shares | 1.50 | Common equity | Long | USA |
HCA HCA Healthcare, Inc. | 83.35 mm | 205.09 k shares | 1.46 | Common equity | Long | USA |
ELV Elevance Health Inc. | 82.36 mm | 158.39 k shares | 1.44 | Common equity | Long | USA |
ASND Ascendis Pharma A/S | 73.97 mm | 495.42 k shares | 1.29 | Long | USA | |
Roche Holdings AG GENUSSCHEINE NPV | 71.09 mm | 222.31 k shares | 1.24 | Preferred equity | Long | Switzerland |
GMED Globus Medical, Inc. | 64.99 mm | 908.49 k shares | 1.13 | Common equity | Long | USA |
BHVN Biohaven Ltd. | 59.28 mm | 1.19 mm shares | 1.03 | Common equity | Long | USA |
AKRO Akero Therapeutics, Inc. | 57.94 mm | 2.02 mm shares | 1.01 | Common equity | Long | USA |
UTHR United Therapeutics Corporation | 55.46 mm | 154.76 k shares | 0.97 | Common equity | Long | USA |
Madrigal Pharmaceuticals, Inc. | 53.72 mm | 253.14 k shares | 0.94 | Common equity | Long | USA |
RVMD Revolution Medicines, Inc. | 53.11 mm | 1.17 mm shares | 0.93 | Common equity | Long | USA |
DYN Dyne Therapeutics, Inc. | 51.33 mm | 1.43 mm shares | 0.90 | Common equity | Long | USA |
HUM Humana Inc. | 47.19 mm | 148.99 k shares | 0.82 | Common equity | Long | USA |
ZTS Zoetis Inc. | 47.15 mm | 241.35 k shares | 0.82 | Common equity | Long | USA |
TFX Teleflex Incorporated | 46.52 mm | 188.11 k shares | 0.81 | Common equity | Long | USA |
MCK McKesson Corporation | 44.94 mm | 90.90 k shares | 0.78 | Common equity | Long | USA |
LNTH Lantheus Holdings, Inc. | 44.93 mm | 409.37 k shares | 0.78 | Common equity | Long | USA |
MDT Medtronic plc | 43.54 mm | 483.64 k shares | 0.76 | Common equity | Long | USA |
RNA Avidity Biosciences, Inc. | 42.74 mm | 930.48 k shares | 0.75 | Common equity | Long | USA |
COO The Cooper Companies, Inc. | 42.02 mm | 380.78 k shares | 0.73 | Common equity | Long | USA |
ACLX Arcellx, Inc. | 40.56 mm | 485.65 k shares | 0.71 | Common equity | Long | USA |
PEN Penumbra, Inc. | 39.73 mm | 204.45 k shares | 0.69 | Common equity | Long | USA |
COR Cencora | 38.76 mm | 172.20 k shares | 0.68 | Common equity | Long | USA |
Teva Pharmaceutical Industries Ltd. SPON ADS EACH REP 1 ORD SHS | 38.05 mm | 2.11 mm shares | 0.66 | Long | USA | |
REGN Regeneron Pharmaceuticals, Inc. | 36.30 mm | 34.53 k shares | 0.63 | Common equity | Long | USA |
INSP Inspire Medical Systems, Inc. | 35.19 mm | 166.73 k shares | 0.61 | Common equity | Long | USA |
AVDL Avadel Pharmaceuticals plc | 35.16 mm | 2.68 mm shares | 0.61 | Common equity | Long | USA |
STE STERIS plc | 34.05 mm | 140.41 k shares | 0.59 | Common equity | Long | USA |
EW Edwards Lifesciences Corporation | 34.02 mm | 515.47 k shares | 0.59 | Common equity | Long | USA |
Zai Lab Ltd. ADS EACH REP 1 ORD SHS | 33.96 mm | 1.41 mm shares | 0.59 | Long | USA | |
GPCR Structure Therapeutics Inc. | 32.66 mm | 744.12 k shares | 0.57 | Long | USA | |
SLNO Soleno Therapeutics, Inc. | 32.39 mm | 641.49 k shares | 0.57 | Common equity | Long | USA |
MIRM Mirum Pharmaceuticals, Inc. | 32.30 mm | 828.13 k shares | 0.56 | Common equity | Long | USA |
ARDX Ardelyx, Inc. | 31.66 mm | 4.59 mm shares | 0.55 | Common equity | Long | USA |
ILMN Illumina, Inc. | 29.48 mm | 226.08 k shares | 0.51 | Common equity | Long | USA |
IDYA IDEAYA Biosciences, Inc. | 27.22 mm | 859.28 k shares | 0.48 | Common equity | Long | USA |
CNC Centene Corporation | 27.05 mm | 359.38 k shares | 0.47 | Common equity | Long | USA |
LEGN Legend Biotech Corporation | 24.84 mm | 509.68 k shares | 0.43 | Long | USA | |
SHC Sotera Health Company | 23.25 mm | 1.39 mm shares | 0.41 | Common equity | Long | USA |
ICLR ICON Public Limited Company | 23.18 mm | 80.69 k shares | 0.40 | Common equity | Long | USA |
HOYA Corp. NPV
|
22.90 mm | 166.30 k shares | 0.40 | Common equity | Long | Japan |
ALNY Alnylam Pharmaceuticals, Inc. | 22.75 mm | 82.73 k shares | 0.40 | Common equity | Long | USA |
MDGL Madrigal Pharmaceuticals, Inc. | 21.95 mm | 2.97 mm shares | 0.38 | Common equity | Long | USA |
GILD Gilead Sciences, Inc. | 21.83 mm | 260.35 k shares | 0.38 | Common equity | Long | USA |
RPRX Royalty Pharma plc | 21.10 mm | 745.86 k shares | 0.37 | Common equity | Long | USA |
CYTK Cytokinetics, Incorporated | 19.62 mm | 371.68 k shares | 0.34 | Common equity | Long | USA |
JANX Janux Therapeutics, Inc. | 19.53 mm | 429.99 k shares | 0.34 | Common equity | Long | USA |
CRNX Crinetics Pharmaceuticals, Inc. | 19.23 mm | 376.27 k shares | 0.34 | Common equity | Long | USA |
PTCT PTC Therapeutics, Inc. | 18.45 mm | 497.35 k shares | 0.32 | Common equity | Long | USA |
FOLD Amicus Therapeutics, Inc. | 17.36 mm | 1.63 mm shares | 0.30 | Common equity | Long | USA |
ALGN Align Technology, Inc. | 17.30 mm | 68.01 k shares | 0.30 | Common equity | Long | USA |
NBIX Neurocrine Biosciences, Inc. | 17.11 mm | 148.48 k shares | 0.30 | Common equity | Long | USA |
Takeda Pharmaceutical Co Ltd. NPV
|
16.19 mm | 567.14 k shares | 0.28 | Common equity | Long | Japan |
INSM Insmed Incorporated | 15.86 mm | 217.26 k shares | 0.28 | Common equity | Long | USA |
EWTX Edgewise Therapeutics, Inc. | 15.62 mm | 585.18 k shares | 0.27 | Common equity | Long | USA |
NEO NeoGenomics, Inc. | 15.55 mm | 1.05 mm shares | 0.27 | Common equity | Long | USA |
DXCM DexCom, Inc. | 14.93 mm | 222.76 k shares | 0.26 | Common equity | Long | USA |
RYTM Rhythm Pharmaceuticals, Inc. | 14.91 mm | 284.69 k shares | 0.26 | Common equity | Long | USA |
IQV IQVIA Holdings Inc. | 13.36 mm | 56.36 k shares | 0.23 | Common equity | Long | USA |
BBIO BridgeBio Pharma, Inc. | 13.20 mm | 518.59 k shares | 0.23 | Common equity | Long | USA |
XENE Xenon Pharmaceuticals Inc. | 12.76 mm | 324.00 k shares | 0.22 | Common equity | Long | USA |
CATX Perspective Therapeutics, Inc. | 12.73 mm | 953.83 k shares | 0.22 | Common equity | Long | USA |
IMNM Immunome, Inc. | 11.69 mm | 799.55 k shares | 0.20 | Common equity | Long | USA |
NGNE Neurogene Inc. | 11.67 mm | 278.17 k shares | 0.20 | Common equity | Long | USA |
CGON CG Oncology, Inc. Common stock | 11.42 mm | 302.66 k shares | 0.20 | Common equity | Long | USA |
Bicara Therapeutics - Series C
|
11.15 mm | 437.83 k shares | 0.19 | Common equity | Long | USA |
GERN Geron Corporation | 11.02 mm | 2.43 mm shares | 0.19 | Common equity | Long | USA |
FDMT 4D Molecular Therapeutics, Inc. | 10.99 mm | 1.02 mm shares | 0.19 | Common equity | Long | USA |
CRGX CARGO Therapeutics, Inc. Common Stock | 10.08 mm | 546.47 k shares | 0.18 | Common equity | Long | USA |
RCKT Rocket Pharmaceuticals, Inc. | 9.90 mm | 536.20 k shares | 0.17 | Common equity | Long | USA |
Janus Henderson Cash Collateral Fund
|
9.64 mm | 9.64 mm shares | 0.17 | Common equity | Long | USA |
Bridgebio Pharma Inc
|
9.06 mm | 355.70 k shares | 0.16 | Common equity | Long | USA |
LXEO Lexeo Therapeutics, Inc. Common Stock | 6.61 mm | 731.18 k shares | 0.12 | Common equity | Long | USA |
HeartFlow Inc - Series F | 6.15 mm | 1.93 mm shares | 0.11 | Preferred equity | Long | USA |
Curevo Inc | 5.71 mm | 2.03 mm shares | 0.10 | Preferred equity | Long | USA |
Shoreline Biosciences Inc | 5.64 mm | 747.19 k shares | 0.10 | Preferred equity | Long | USA |
BCAX Bicara Therapeutics Inc. Common Stock | 5.22 mm | 205.13 k shares | 0.09 | Common equity | Long | USA |
Attralus Inc | 5.20 mm | 669.94 k shares | 0.09 | Preferred equity | Long | USA |
Sonoma Biotherapeutics Inc - Series B | 4.81 mm | 1.26 mm shares | 0.08 | Preferred equity | Long | USA |
Element Biosciences Inc | 4.14 mm | 425.02 k shares | 0.07 | Preferred equity | Long | USA |
Magnolia Medical Technologies | 3.01 mm | 1.82 mm shares | 0.05 | Preferred equity | Long | USA |
Asher Biotherapeutics - Series C | 3.00 mm | 2.58 mm shares | 0.05 | Preferred equity | Long | USA |
Sonoma Biotherapeutics Inc - Series B-1 | 2.56 mm | 669.43 k shares | 0.04 | Preferred equity | Long | USA |
Royal Bank of Canada | 2.41 mm | 2.41 mm principal | 0.04 | Short-term investment vehicle | Long | USA |
Freenome Holdings Inc - Series D | 1.91 mm | 342.80 k shares | 0.03 | Preferred equity | Long | USA |
Freenome Holdings Inc - Series C | 1.87 mm | 337.47 k shares | 0.03 | Preferred equity | Long | USA |
Asher Biotherapeutics Inc | 1.41 mm | 1.21 mm shares | 0.02 | Preferred equity | Long | USA |
TwinStrand Biosciences Inc | 1.38 mm | 344.31 k shares | 0.02 | Preferred equity | Long | USA |
Janus Henderson Cash Liquidity Fund LLC
|
1.20 mm | 1.20 mm shares | 0.02 | Common equity | Long | USA |
Curevo Inc. Series SAFE | 874.61 k | 87.46 mm shares | 0.02 | Preferred equity | Long | USA |
Arbor Biotechnologies Inc | 642.91 k | 156.43 k shares | 0.01 | Preferred equity | Long | USA |
Magnolia Medical Technologies | 384.51 k | 384.51 k principal | 0.01 | Debt | Long | USA |
Magnolia Medical Technologies
|
37.75 | 37.75 k shares | 0.00 | Common equity | Long | USA |
CMTA Clementia Pharmaceuticals Inc. | 0.87 | 874.31 k shares | 0.00 | Long | USA | |
Magnolia Medical Technologies
|
0 | 1.00 shares | 0.00 | Common equity | Long | USA |